Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Denise Yardley, M.D.
SCRI Development Innovations, LLC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Medical Oncology Associates of Augusta
Augusta, Georgia, United States
- Providence Medical Group
Terre Haute, Indiana, United States
- Mercy Hospital
Portland, Maine, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- National Capital Clinical Research Consortium
Bethesda, Maryland, United States
- Grand Rapids Clinical Oncology Program
Grand Rapids, Michigan, United States
- St. Louis Cancer Care
Chesterfield, Missouri, United States
- Hematology Oncology Associates of Northern Nj
Morristown, New Jersey, United States
- Oncology Hematology Care
Cincinnati, Ohio, United States
- Tennessee Oncology, Pllc
Nashville, Tennessee, United States
- Virginia Cancer Institute
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2009
- Primary completion
- 31 Jul 2011
- Completion
- 31 Oct 2014
- Last update posted
- 22 Dec 2014
- Registered enrollment
- 60
- Registry id
- NCT00821886
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.